MICHAEL D. DALE - 26 Feb 2026 Form 4 Insider Report for Axogen, Inc. (AXGN)

Signature
/s/ Mark Began, as attorney-in-fact for Michael Dale
Issuer symbol
AXGN
Transactions as of
26 Feb 2026
Net transactions value
$0
Form type
4
Filing time
27 Feb 2026, 16:20:02 UTC
Previous filing
12 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DALE MICHAEL D Chief Executive Officer 13631 PROGRESS BLVD.,, SUITE 400, ALACHUA /s/ Mark Began, as attorney-in-fact for Michael Dale 27 Feb 2026 0001172346

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Restricted Stock Units Award $0 +98,000 $0.000000 98,000 26 Feb 2026 Common Stock 98,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F2 All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.